Because of the postponement of ILC4 2020 until September, 2022, the Abstract Submission site is closed and will reopen in February, 2022.

Abstract Submission Categories:

  1. ILC Development and Trajectories
  2. ILC Tissue Niches
  3. ILC1s and NK cells
  4. ILC2s
  5. ILC3s
  6. Central and Peripheral Nervous System and ILCs
  7. ILCs and Metabolism
  8. ILCs and Cancer
  9. ILCs and Atopic Diseases
  10. ILCs and Inflammatory Diseases
  11. Human ILCs
  12. Therapeutics

Abstract Submission Guidelines

  • Only create one account for abstract submission & registration, as they will be connected to your profile, you can submit more than one abstract
  • Abstract body: (approximately 300 words)
  • Select your presentation preference, oral presentation, poster presentation or no preference (oral or poster presentation).
  • Include all authors and affiliations in submission (this is the 2nd step), including the submitting author, any co-authors. Author names should be in the first name-last name format. Please do not use all capital letters. Ex.) Jane E. Smith.  Please include Co-Authors names, affiliation, city, country and email address (so they can be notified regarding the submission)
  • All abstracts must be submitted and presented in English with spelling and grammar of a quality suitable for electronic publication
  • All submissions will appear in the online program the exact way they are submitted
  • Abstracts must be submitted by the presenting author, advisors may not submit an abstract for another person under their own login.

Review Procedures

  • All submissions are reviewed by the International Organizing Committee
  • Proposals constituting sales pitches for products or services will not be considered
  • Any oral submissions not chosen for an oral presentation will receive a poster presentation
  • Authors will be notified of the abstract acceptance/rejection by mid July

When you’ve finished the submission

Submitted abstracts will be reviewed and selected by abstract review groups that include members of the Organizing Committee and International Organizing Committee, for oral or poster presentation AFTER THE new deadline.

You will receive a confirmation email with your Abstract Submission ID number after your abstract submission has been successfully submitted. You can view or edit your abstract by returning to your profile in the ILC4 Conference Management system at any time before the submission deadline. If you do not receive this confirmation email, please contact the Conference Manager, Joan Oefner.

Meeting Organization & Support Teams

MCI Suisse SA is the official meeting organizer to process registrations, abstract management.

Cytokines 2022 c/o MCI Suisse SA

9 Rue de Pré-Bouvier 1242, Satigny, Geneva, Switzerland
+41 22 33 99 524 [email protected]

International Cytokine & Interferon Society (ICIS)

ILC4 is now organized under the auspices of the International Cytokine & Interferon Society (ICIS). For information about Awards, Sponsorship or Exhibition, please contact ICIS Managing Director, Joan Oefner: [email protected]
or visit the ICIS website

Telephone: 1-800-947-1960 

WhatsApp: +49 171-1049-181